Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Wendy K D Selig

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Cancer Causes & Control : CCC|October 7, 2005
Examining advocacy and comprehensive cancer controlWendy K D Selig, K Larry Jenkins, Steven L Reynolds, et al.
Research Involvement and Engagement|March 1, 2023
Adopting recommendations for implementing patient involvement in cancer research: a funder's approachAlexandre B Costa Alencar, Wendy K D Selig, Jan Geissler, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 31, 2013
Developing standards for breakthrough therapy designation in oncologySandra J Horning, Daniel A Haber, Wendy K D Selig, et al.
Therapeutic Innovation & Regulatory Science|August 27, 2022
Leveraging Patient Preference Information in Medical Device Clinical Trial DesignLiliana Rincon-Gonzalez, Wendy K D Selig, Brett Hauber, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|May 26, 2018
Making Lung Cancer Clinical Trials More Inclusive: Recommendations for Expanding Eligibility CriteriaPhilip Bonomi, Gideon Blumenthal, Andrea Stern Ferris, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|December 10, 2024
Contributions of neurologists to diagnostic timelines of ALS and thinkALS as an early referral instrument for cliniciansKuldip D Dave, Björn Oskarsson, Jill Yersak, et al.
Journal of Cachexia, Sarcopenia and Muscle|February 26, 2022
Addressing unmet needs for people with cancer cachexia: recommendations from a multistakeholder workshopJose M Garcia, Richard F Dunne, Kristen Santiago, et al.
Journal for Immunotherapy of Cancer|May 19, 2019
The promise of Immuno-oncology: implications for defining the value of cancer treatmentHoward L Kaufman, Michael B Atkins, Prasun Subedi, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Cancer Causes & Control : CCC|October 7, 2005
Examining advocacy and comprehensive cancer controlWendy K D Selig, K Larry Jenkins, Steven L Reynolds, et al.
Research Involvement and Engagement|March 1, 2023
Adopting recommendations for implementing patient involvement in cancer research: a funder's approachAlexandre B Costa Alencar, Wendy K D Selig, Jan Geissler, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 31, 2013
Developing standards for breakthrough therapy designation in oncologySandra J Horning, Daniel A Haber, Wendy K D Selig, et al.
Therapeutic Innovation & Regulatory Science|August 27, 2022
Leveraging Patient Preference Information in Medical Device Clinical Trial DesignLiliana Rincon-Gonzalez, Wendy K D Selig, Brett Hauber, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|May 26, 2018
Making Lung Cancer Clinical Trials More Inclusive: Recommendations for Expanding Eligibility CriteriaPhilip Bonomi, Gideon Blumenthal, Andrea Stern Ferris, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|December 10, 2024
Contributions of neurologists to diagnostic timelines of ALS and thinkALS as an early referral instrument for cliniciansKuldip D Dave, Björn Oskarsson, Jill Yersak, et al.
Journal of Cachexia, Sarcopenia and Muscle|February 26, 2022
Addressing unmet needs for people with cancer cachexia: recommendations from a multistakeholder workshopJose M Garcia, Richard F Dunne, Kristen Santiago, et al.
Journal for Immunotherapy of Cancer|May 19, 2019
The promise of Immuno-oncology: implications for defining the value of cancer treatmentHoward L Kaufman, Michael B Atkins, Prasun Subedi, et al.
Pageof 1